In search of a Ku­ur: Cell Med­ica re­brands and re­groups, tak­ing a new name, a new CEO and new mon­ey

Four years af­ter Lon­don-based up­start Cell Med­ica teamed up with Bay­lor to work on next-gen cell ther­a­pies, the com­pa­ny is do­ing a com­plete makeover and adding some new cash to the re­serves.

Out goes the name. Cell Med­ica is now Ku­ur Ther­a­peu­tics, which is look­ing to launch a new Phase I study, match­ing the first one in the clin­ic, us­ing their chimeric anti­gen re­cep­tor nat­ur­al killer T cell (CAR-NKT) ther­a­py plat­form. Ku­ur is based in Hous­ton, close to its part­ners at Bay­lor.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER